India Thrombosis Treatment Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India Thrombosis Treatment Market was valued at USD 10.0 million in 2025 and is projected to reach USD 14.74 million by 2032, growing at a CAGR of approximately 5.7% during 2026–2032.
India Thrombosis Treatment Market Highlights
| Report Metric | Details |
| Report Name | India Thrombosis Treatment Market |
| Market Size 2025 | USD 10.0 million |
| Market Size 2032 | USD 14.74 million |
| Absolute Growth 2025–2032 | USD 4.74 million |
| CAGR 2026–2032 | 5.7% |
| Peak Annual Growth | 8.5% in 2032 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Treatment Type, 2025 | Pharmacologic Therapy (51% share) |
| Leading Patient Category, 2025 | Adult Patients (40% share) |
| Leading Delivery Setting, 2025 | Inpatient (48% share) |
| Leading End User, 2025 | Hospitals (45% share) |
| Fastest-Growing Treatment Type | Catheter-Directed Therapy (7.5% CAGR) |
| Fastest-Growing Patient Category | High-Risk Cases (8.2% CAGR) |
| Fastest-Growing Delivery Setting | Cath Lab (7.9% CAGR) |
| Fastest-Growing End User | Surgical Centers (7.7% CAGR) |
| Growing Sector | Surgical Centers |
| Key End Users | Hospitals, Surgical Centers, Multispecialty Clinics, Interventional Radiology |
India Thrombosis Treatment Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
The table below sets out the estimated growth rate for each year and the main factor behind it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 3.0 | The market experienced steady growth due to the National Health Mission's initiatives to improve healthcare access. |
| 2023 | 4.7 | Growth accelerated as hospitals expanded their thrombosis treatment capabilities through new investments. |
| 2024 | 3.5 | The market growth slowed as hospitals faced resource allocation challenges amid rising patient numbers. |
| 2025 | 4.2 | Demand increased as healthcare investments improved access to thrombosis treatment across regions. |
| 2026 | 3.4 | Growth is expected to slow as hospitals adapt to updated treatment protocols and guidelines. |
| 2027 | 8.0 | A surge in demand is projected due to the introduction of new anticoagulant medications in 2023. |
| 2028 | 4.8 | Market growth is expected to decelerate as hospitals manage increasing patient loads and treatment complexities. |
| 2029 | 4.3 | Growth is projected to continue slowing as healthcare providers adapt to evolving treatment guidelines. |
| 2030 | 3.2 | The market's growth rate is expected to decrease as competition intensifies among treatment facilities. |
| 2031 | 7.8 | Demand is projected to surge again as awareness campaigns effectively educate the public on thrombosis risks. |
| 2032 | 8.5 | The market is expected to peak as advancements in treatment options and healthcare access reach new heights. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India Thrombosis Treatment Market Synopsis
Thrombosis Treatment in India involves managing blood clots through medications and surgical procedures. This treatment primarily utilises pharmacological formulations and surgical techniques to address conditions like deep vein thrombosis and pulmonary embolism. The India Thrombosis Treatment Market is expanding due to substantial healthcare investments, with $11 billion in foreign direct investment in 2022. The National Health Mission aims to improve healthcare access, driving demand for thrombosis management services and benefiting a large patient demographic.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increasing prevalence of thrombosis due to lifestyle changes in urban areas. | Driver | High | Pharmacologic Therapy |
| Growing elderly population requiring thrombosis treatment. | Driver | High | Adult Patients |
| Rising demand for specialized medical devices for thrombosis treatment. | Opportunity | High | Surgical Thrombectomy |
| Expansion of healthcare facilities in metropolitan areas. | Opportunity | High | Cath Lab |
| Limited awareness of thrombosis symptoms among the general population. | Restraint | Medium | Combined Therapy |
| High costs associated with advanced treatment options. | Restraint | Medium | Catheter-Directed Therapy |
| Regulatory hurdles in the approval of new treatment protocols. | Challenge | High | Surgical Thrombectomy |
| Inconsistent availability of specialized medical staff for treatment. | Challenge | High | Inpatient |
Evaluation of Drivers in India Thrombosis Treatment Market (2026–2032)
Below mentioned are some major drivers and their influence on market dynamics.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increased healthcare investments improving treatment access. | Pharmacologic Therapy | The Indian healthcare sector received $11 billion in foreign direct investment in 2022, improving treatment availability. |
| Growing elderly demographic requiring thrombosis management. | Adult Patients | The elderly population is expanding, increasing treatment demand among the 1.4 billion population. |
| Rising awareness of thrombosis risks and symptoms. | Combined Therapy | Education initiatives have led to more patients seeking treatment options, increasing demand. |
| Advancements in anticoagulant medications improving treatment options. | Surgical Thrombectomy | New anticoagulants approved in 2023 have improved treatment efficacy for patients. |
| Expansion of specialized healthcare facilities in urban areas. | Cath Lab | Higher volumes of thrombosis cases in metropolitan surgical centers drive demand for specialized services. |
The Thrombosis Treatment market in India is growing due to increased healthcare investments, advancements in treatment options, and rising awareness of thrombosis risks. The healthcare sector received $11 billion in foreign direct investment in 2022, improving access to treatment facilities across the country. The expanding elderly population is increasing demand for thrombosis management, with about 1 in 1,000 adults affected annually. New anticoagulant medications approved in 2023 have improved treatment efficacy, encouraging more patients to seek care.
Evaluation of Restraints in India Thrombosis Treatment Market
The main factors holding the market back are set out below.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory delays extending approval times for new medications. | Pharmacologic Therapy | These delays can cost hospitals valuable time in delivering care to patients requiring immediate treatment. |
| Skills shortages among healthcare professionals. | Surgical Thrombectomy | This shortage impedes effective thrombosis management, resulting in increased treatment costs for patients and facilities. |
| Rising surgical procedure costs driven by advanced technologies. | Catheter-Directed Therapy | These costs can impose significant out-of-pocket expenses on patients, particularly in metropolitan areas. |
| Competition from alternative treatment options. | Combined Therapy | This competition pressures suppliers to lower prices, which may compromise the quality of care patients receive. |
| Limited awareness of thrombosis symptoms among patients. | Adult Patients | This lack of awareness can lead to delayed diagnosis and treatment, negatively affecting patient outcomes. |
India Thrombosis Treatment Market Challenges
Buyers in the India thrombosis treatment market face regulatory delays that can extend approval times for new medications and devices, costing hospitals up to three months in delivering critical care. Skills shortages among healthcare professionals hinder effective thrombosis management, leading to increased treatment costs that burden patients and healthcare facilities. Rising surgical procedure costs, driven by the need for advanced technologies, can impose out-of-pocket expenses averaging ₹50,000 on patients, particularly in metropolitan areas with higher demand. Competition from alternative treatment options pressures suppliers to reduce prices, potentially compromising the quality of care for patients.
Trends in the India Thrombosis Treatment Market
Several trends are reshaping the India Thrombosis Treatment Market; the most important are set out below.
- Shift towards Advanced Anticoagulant Therapies: The introduction of new anticoagulant medications in 2023 is transforming treatment protocols, improving patient outcomes. This shift is attracting more patients seeking thrombosis management solutions, particularly in urban healthcare settings.
- Growth in Urban Healthcare Facilities: In urban areas, the number of specialized surgical centers has increased, accommodating higher volumes of thrombosis cases. This trend is driving demand for advanced treatment options and improving patient care across metropolitan regions.
- Increased Focus on Patient Education: Since 2022, healthcare providers have intensified efforts to educate patients about thrombosis risks and symptoms. This focus is leading to earlier diagnosis and increased treatment-seeking behaviour among patients, enhancing overall care.
- Expansion of Insurance Coverage for Treatment: The Pradhan Mantri Jan Arogya Yojana, initiated in 2018, has expanded health insurance coverage for thrombosis treatment. This expansion is projected to increase access to necessary treatments for millions of families across India.
Investment Opportunities in the India Thrombosis Treatment Market
Below are the investment opportunities with the strongest case in the India Thrombosis Treatment Market.
- Growing Demand for Catheter-Directed Therapy: With a projected growth rate of 7.5%, there is a strong opportunity to supply catheter-directed therapy solutions. Hospitals are increasingly seeking these advanced treatment options to manage specific clot locations effectively.
- Investment in Surgical Centers: The rising number of thrombosis cases presents an opportunity to invest in surgical centers. Urban areas, where demand is highest, are ideal for establishing new facilities to cater to this growing need.
- Partnerships for Advanced Treatment Solutions: Healthcare providers are looking for partnerships to enhance treatment offerings. Collaborating with hospitals can facilitate the introduction of innovative thrombosis treatment solutions that meet patient needs.
- Focus on Elderly Patient Care: The growing elderly demographic creates an opportunity to supply specialized thrombosis management services. Targeting healthcare facilities that cater to this age group can lead to successful market entry and improved patient outcomes.
Government Initiatives in the India Thrombosis Treatment Market
The Ministry of Health and Family Welfare updated the National Guidelines for Thrombosis Management in 2021 to standardize treatment protocols across hospitals. This measure ensures consistency in care delivery and improves patient outcomes by providing clear guidelines for healthcare providers. Additionally, the National Health Mission continues to support healthcare access, with an annual budget of ₹30,000 crores for various health initiatives, including thrombosis treatment.
The Indian Council of Medical Research launched a national study on thrombosis prevalence in 2022 to inform public health strategies. This study provides valuable data that can help healthcare providers and policymakers improve thrombosis management and awareness initiatives across the country. Furthermore, the Pradhan Mantri Jan Arogya Yojana, initiated in 2018, offers health insurance coverage for thrombosis treatment, benefiting over 50 million families and enabling patients to access necessary treatments without financial burden.
Future Insight of the India Thrombosis Treatment Market
The India thrombosis treatment market will experience transformative changes by 2032, with advancements in surgical techniques and pharmacologic therapy driving improvements. The 'Ayushman Bharat' scheme will enhance access to thrombosis management for millions, particularly benefiting the growing elderly demographic. With healthcare investments projected to reach $15 billion, service delivery will strengthen across over 1,500 hospitals equipped for thrombosis treatment. Increased awareness initiatives from the Indian Society of Hematology will promote early diagnosis and intervention, ultimately improving patient outcomes.
Market Segmentation Analysis
Each segment group is reviewed below, with the leader by share and the fastest grower by CAGR.
By Treatment Type – Pharmacologic Therapy Dominated, Catheter-Directed Therapy Expected to Grow Fastest
According to Vasudha, AM at 6Wresearch, Pharmacologic Therapy held a 51% share of the India Thrombosis Treatment Market by treatment type in 2025. Pharmacologic therapy holds the largest share in the India thrombosis treatment market due to its essential role in managing conditions like deep vein thrombosis. This method is the first-line treatment for 80% of thrombosis cases, highlighting its critical importance in patient care. Catheter-Directed Therapy is projected to grow fastest, at a CAGR of 7.5% during 2026–2032. Catheter-directed therapy is witnessing rapid growth as it allows for targeted treatment of clots in specific locations, responding to the increasing prevalence of thrombosis. The lifestyle changes in urban areas have led to a higher demand for such specialised interventions, further driving its adoption. Suppliers should enhance pharmacologic offerings while investing in catheter-directed technologies to meet the growing demand.
By Patient Category – Adult Patients Dominated, High-Risk Cases Expected to Grow Fastest
Adult Patients accounted for a 40% market share by patient category in 2025. Adult patients represent the largest share of the thrombosis treatment market in India, as they are the primary demographic affected by conditions like deep vein thrombosis. With a significant portion of the population aged around 60 years, this group is crucial for effective treatment services. High-Risk Cases are set to record the highest CAGR in this split, 8.2% over 2026–2032. High-risk cases are the fastest-growing segment, driven by the increasing number of patients with pre-existing conditions that elevate clotting risks. As awareness and screening improve, more high-risk individuals are being identified and treated, contributing to this rapid growth. Providers must tailor their services to address the specific needs of high-risk patients to capture this expanding market.
By Delivery Setting – Inpatient Dominated, Cath Lab Expected to Grow Fastest
The largest delivery setting category in 2025 was Inpatient, with a 48% share of total revenue. Inpatient settings dominate the thrombosis treatment market as they are the common environment for acute treatment of thrombosis cases. With over 1,500 hospitals equipped for such treatments, this segment is well-established and vital for patient care. Over 2026–2032, Cath Lab is expected to post the fastest growth, at a CAGR of 7.9%. Cath labs are witnessing the fastest growth due to their focus on catheter-directed procedures, which are becoming increasingly popular for targeted clot management. This trend reflects the shift towards more advanced treatment options in urban healthcare facilities. Healthcare facilities should consider expanding cath lab capabilities to stay competitive in the evolving treatment landscape.
By End User – Hospitals Dominated, Surgical Centers Expected to Grow Fastest
In 2025, Hospitals led the end user split with a 45% share. Hospitals command the largest share of the thrombosis treatment market, serving as the primary facilities that provide comprehensive treatment services. Their established infrastructure and resources make them essential for managing thrombosis effectively across various patient demographics. The quickest growth will come from Surgical Centers, forecast to expand at a CAGR of 7.7% between 2026 and 2032. Surgical centers are growing rapidly as they specialise in surgical interventions for thrombosis, catering to the rising demand for advanced treatment options. This growth is driven by the increasing number of patients requiring surgical procedures in metropolitan areas. Investing in surgical center partnerships could enhance service delivery and patient outcomes in thrombosis treatment.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India Thrombosis Treatment Market Outlook
- Market Size of India Thrombosis Treatment Market, 2025
- Forecast of India Thrombosis Treatment Market, 2032
- Historical Data and Forecast of India Thrombosis Treatment Revenues & Volume for the Period 2022 - 2032F
- India Thrombosis Treatment Market Trend Evolution
- India Thrombosis Treatment Market Drivers and Challenges
- India Thrombosis Treatment Price Trends
- India Thrombosis Treatment Porter's Five Forces
- India Thrombosis Treatment Industry Life Cycle
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Treatment Type for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Pharmacologic Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Surgical Thrombectomy for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Catheter-Directed Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Combined Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Patient Category for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Adult Patients for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By High-Risk Cases for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Elderly Patients for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Chronic Cases for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Delivery Setting for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Inpatient for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Operation Theater for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Cath Lab for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Long-Term Care Units for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Surgical Centers for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Interventional Radiology for the Period 2022 - 2032F
- Historical Data and Forecast of India Thrombosis Treatment Market Revenues & Volume By Multispecialty Clinics for the Period 2022 - 2032F
- India Thrombosis Treatment Import Export Trade Statistics
- Market Opportunity Assessment By Treatment Type
- Market Opportunity Assessment By Patient Category
- Market Opportunity Assessment By Delivery Setting
- Market Opportunity Assessment By End User
- India Thrombosis Treatment Top Companies Market Share
- India Thrombosis Treatment Competitive Benchmarking By Technical and Operational Parameters
- India Thrombosis Treatment Company Profiles
- India Thrombosis Treatment Key Strategic Recommendations
Market Covered
Segments analysed in this report are listed below.
By Treatment Type
- Pharmacologic Therapy
- Surgical Thrombectomy
- Catheter-Directed Therapy
- Combined Therapy
By Patient Category
- Adult Patients
- High-Risk Cases
- Elderly Patients
- Chronic Cases
By Delivery Setting
- Inpatient
- Operation Theater
- Cath Lab
- Long-Term Care Units
By End User
- Hospitals
- Surgical Centers
- Interventional Radiology
- Multispecialty Clinics
